Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 17951-18000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06889480
Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
NARecruiting
5 participants
Started: Oct 1, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT06606821
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
PHASE4Recruiting
124 participants
Started: Oct 1, 2024 · Completed: Aug 1, 2028
6 conditions1 sponsor3 locations
NCT06584045
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
NARecruiting
250 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2029
4 conditions2 sponsors1 location
NCT06494579
Lamivudine for Solid Tumors
PHASE1/PHASE2Recruiting
24 participants
Started: Sep 30, 2024 · Completed: Jul 15, 2027
1 condition1 sponsor1 location
NCT06551961
Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation
NARecruiting
35 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT06525597
Study of Stapokibart Injection in Patients With Allergic Rhinitis
PHASE2Recruiting
120 participants
Started: Sep 30, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06640504
Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
N/ARecruiting
30 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06626243
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
N/ARecruiting
140 participants
Started: Sep 30, 2024 · Completed: Oct 15, 2025
1 condition6 sponsors6 locations
NCT06603311
Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection
NARecruiting
20 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
2 conditions3 sponsors5 locations
NCT06349304
Impact of Grape Powder Consumption on Eye Health and Glycemic Status in Singapore Older Adults
NARecruiting
46 participants
Started: Sep 30, 2024 · Completed: Aug 1, 2025
3 conditions2 sponsors1 location
NCT06497140
Effect of Genicular Arteries Embolization in Symptomatic Knee Osteoarthritis LipioJoint-2
PHASE3Recruiting
130 participants
Started: Sep 30, 2024 · Completed: Oct 1, 2028
1 condition2 sponsors3 locations
NCT06609304
Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
PHASE4Recruiting
20 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT07213440
Identification of Early Markers for ALS
NARecruiting
60 participants
Started: Sep 30, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT03981640
Neural Control of Kidney Blood Flow During Exercise in African American Adults
NARecruiting
32 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06574269
A Study on TLC590 for Managing Postsurgical Pain
PHASE2Recruiting
120 participants
Started: Sep 30, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor2 locations
NCT06602011
Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
N/ARecruiting
20 participants
Started: Sep 30, 2024 · Completed: Oct 1, 2028
1 condition1 sponsor6 locations
NCT06531863
Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
EARLY_PHASE1Recruiting
64 participants
Started: Sep 30, 2024 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06569498
Neoadjuvant Triple Therapy for Resectable HCC
N/ARecruiting
20 participants
Started: Sep 30, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor6 locations
NCT06399809
Fisetin to Reduce Senescence and Mobility Impairment in PAD
PHASE2Recruiting
34 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2027
5 conditions1 sponsor1 location
NCT06672692
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
NARecruiting
1,000 participants
Started: Sep 30, 2024 · Completed: May 31, 2025
4 conditions1 sponsor3 locations
NCT06651606
Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis
NARecruiting
24 participants
Started: Sep 30, 2024 · Completed: Sep 10, 2026
1 condition2 sponsors2 locations
NCT06479070
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
NARecruiting
188 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2029
2 conditions1 sponsor7 locations
NCT06471543
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
PHASE1/PHASE2Recruiting
108 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2026
2 conditions1 sponsor9 locations
NCT06634290
Influence of Cemented Cephalic Augmentation on the Outcome of Intramedullary Nailing in Pertrochanteric Hip Fractures
NARecruiting
314 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor6 locations
NCT06442904
Can a Digital Education Program in Radiographic Imaging Technique for Dental Professionals Improve Image Quality?
NARecruiting
90 participants
Started: Sep 30, 2024 · Completed: Jan 31, 2025
2 conditions2 sponsors1 location
NCT06434727
Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures.
N/ARecruiting
80 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor4 locations
NCT06587399
Comparison of Manual Therapy Versus Radial Shock Waves in the Shoulder Pain Treatment
NARecruiting
88 participants
Started: Sep 30, 2024 · Completed: Sep 15, 2026
2 conditions1 sponsor1 location
NCT06577272
Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
N/ARecruiting
6,000 participants
Started: Sep 30, 2024 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06068543
Reducing Frailty for Older Cancer Survivors Using Supplements II
PHASE2Recruiting
118 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT06568055
A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom
N/ARecruiting
672 participants
Started: Sep 30, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04390009
Entire-body PET Scans for Multiple Sclerosis
EARLY_PHASE1Recruiting
20 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06600126
Supporting Evidence-based Responses to Emotional Needs in Emphysema
NARecruiting
750 participants
Started: Sep 30, 2024 · Completed: Mar 5, 2028
1 condition4 sponsors2 locations
NCT06685666
Effects of Band Exercises Added to the Warm-Up on Shooting and Viscoelastic Properties of Muscles in Handball Players
NARecruiting
30 participants
Started: Sep 30, 2024 · Completed: Jan 30, 2025
2 conditions1 sponsor1 location
NCT06269120
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
N/ARecruiting
470 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05527145
Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial
NARecruiting
200 participants
Started: Sep 30, 2024 · Completed: Jul 31, 2026
4 conditions1 sponsor1 location
NCT06440408
Calculating Wall Shear Stress in Infant Pulmonary Veins
PHASE1Recruiting
20 participants
Started: Sep 30, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06604689
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
N/ARecruiting
800 participants
Started: Sep 30, 2024 · Completed: Oct 1, 2025
2 conditions1 sponsor1 location
NCT06044311
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
PHASE2Recruiting
25 participants
Started: Sep 30, 2024 · Completed: Jun 1, 2027
4 conditions1 sponsor1 location
NCT06259994
Dexamethasone and Pregnancy: Maternal Effects
N/ARecruiting
35 participants
Started: Sep 30, 2024 · Completed: Dec 30, 2028
1 condition1 sponsor17 locations
NCT06422845
Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis
NARecruiting
328 participants
Started: Sep 30, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor33 locations
NCT06649162
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
N/ARecruiting
10,000 participants
Started: Sep 30, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor2 locations
NCT06430580
Cannabinoids and Biological Reactivity to Stress
EARLY_PHASE1Recruiting
36 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
1 condition4 sponsors1 location
NCT06654557
Effect of Adding Glycerol to Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest
NARecruiting
95 participants
Started: Sep 30, 2024 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT06574126
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
PHASE2Recruiting
20 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2032
1 condition1 sponsor1 location
NCT06660992
A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
PHASE3Recruiting
669 participants
Started: Sep 30, 2024 · Completed: Jan 27, 2027
1 condition1 sponsor2 locations
NCT06608797
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
NARecruiting
40 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06609239
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.
PHASE2Recruiting
900 participants
Started: Sep 30, 2024 · Completed: Jan 20, 2031
1 condition1 sponsor100 locations
NCT06457230
Paired-pulse rTMS Treatment for Methamphetamine Use Disorder Based on the Frontopolar-Cerebellum
NARecruiting
40 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06493019
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
PHASE2Recruiting
23 participants
Started: Sep 30, 2024 · Completed: Apr 14, 2027
1 condition3 sponsors4 locations
NCT06592989
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
N/ARecruiting
20 participants
Started: Sep 30, 2024 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location